David R. Walt, Director at Cerulean Pharma Inc. (CERU), bought 8,960 shares at $2.12 ($19K) on 2016-02-17, disclosed to the SEC on 2016-02-19.
Scheduled purchase ($19k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.12 | 4,460 | $9K | 50.1% |
| 2 | $2.09 | 4,500 | $9K | 49.9% |
| Total | $2.10 avg | 8,960 | $19K | 100% |
| Filing → |
| QTRX | BUY | 2024-09-17 | $625K | — | Filing → |
| QTRX | BUY | 2022-08-10 | $2.6M | — | Filing → |
| QTRX | BUY | 2020-03-17 | $1.8M | — | Filing → |